Advance Publication by J-STAGE jea JE2007446

Background: H5N2 avian influenza virus infection of humans has not been reported thus far. The first H5N2 avian influenza infection of poultry in Japan occurred in Ibaraki. Methods: The subjects were workers at 35 chicken farms in Ibaraki Prefecture, where the H5N2 virus or antibody was isolated from chickens. None of the subjects exhibited influenza symptoms. The H5N2-neutralizing antibody titers of the first and second paired sera samples were compared. To investigate the possible factors for this increase, the H5N2-neutralizing antibody titer (1:40 or more) was calculated for the second samples. A logistic regression analysis was performed to examine the association of these factors with H5N2-neutralizing antibody positivity. Results: We performed Wilcoxon matched-pairs signed-ranked test on data collected from 257 subjects, and determined that the H5N2 antibody titers of the second paired sera samples were significantly higher than those of the first samples (P < 0.001). The H5N2 antibody titers of paired sera of 13 subjects without a history of seasonal influenza vaccination within the previous 12 months increased 4-fold or more. The percentage of antibody positivity was 32% for subjects with a history of seasonal influenza vaccination (28% of all subjects) and 13% for those without a history of the same. The adjusted odds ratio of H5N2-neutralizing antibody positivity was 4.6 (95% confidence interval: 1.6-13.7) for those aged over 40 and 3.1 (95% confidence interval: 1.6-6.1) for those with a history of seasonal influenza vaccination within the previous 12 months. Conclusion: The results suggest that this may have been the first avian influenza H5N2 infection of poultry to affect humans. A history of seasonal influenza vaccination might be associated with H5N2-neutralizing antibody positivity.

[1]  C. Agrati,et al.  Cross-subtype Immunity against Avian Influenza in Persons Recently Vaccinated for Influenza , 2008, Emerging infectious diseases.

[2]  M. Okamatsu,et al.  Low pathogenicity H5N2 avian influenza outbreak in Japan during the 2005-2006. , 2007, Veterinary microbiology.

[3]  A. Capuano,et al.  Infection due to 3 avian influenza subtypes in United States veterinarians. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  M. Okamatsu,et al.  Characterization of H5N2 Influenza A Viruses Isolated from Chickens in Japan , 2007, Avian diseases.

[5]  Larry R. Smith,et al.  Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans , 2007, PLoS medicine.

[6]  Martin Hirst,et al.  Human Illness from Avian Influenza H7N3, British Columbia , 2004, Emerging infectious diseases.

[7]  D. Suarez,et al.  Effect of Vaccine Use in the Evolution of Mexican Lineage H5N2 Avian Influenza Virus , 2004, Journal of Virology.

[8]  T. Kuiken,et al.  Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[9]  W. Thompson,et al.  Observations on mortality during the 1918 influenza pandemic. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  M. Peiris,et al.  Human infection with influenza H9N2 , 1999, The Lancet.

[11]  R. Webster,et al.  Origin and molecular changes associated with emergence of a highly pathogenic H5N2 influenza virus in Mexico. , 1995, Virology.

[12]  C. Naeve,et al.  Is virulence of H5N2 influenza viruses in chickens associated with loss of carbohydrate from the hemagglutinin? , 1984, Virology.

[13]  F. Hayden.  Writing Committee of the Second World Health Organization (WHO) Consultation on Clinical Aspects of Human Infection with Avian Influenza A(H5N1) Virus , 2007 .

[14]  Uenza Manu.  WHO Manual on Animal Influenza Diagnosis and Surveillance , 2002 .